Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Shockwave Medical's CMO discusses the C2 Aero launch, why the company is defining what qualifies as true IVL, and J&J's R&D ...

A new survey undertaken by the Harris Poll for Johnson & Johnson has shown how standard forms of surgery and treatment for ...

During the study, investigators completed all procedures robotically on OTTAVA without conversion to a non-robotic approach.

The case, which opened in the High Court on Wednesday, originally involved 3,000 claimants and is set to become the largest product liability case in UK history.

J&J has launched its Shockwave C2 Aero Coronary IVL Catheter globally, marking an advancement in the treatment of calcified ...

Johnson & Johnson MedTech is touting positive results from the first clinical study of its Ottava soft-tissue surgical robot, ...

By Michael Erman NEW YORK, April 27 (Reuters) - Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for developing drugs, the company's chief ...

The trial features the family members of three women who died of ovarian cancer after decades of using Johnson & Johnson’s ...

J&J investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease: Chicago, Illinois Thursd ...